| Followers | 10 |
| Posts | 1578 |
| Boards Moderated | 0 |
| Alias Born | 10/15/2014 |
Wednesday, June 27, 2018 10:54:12 AM
I think it has more to do with stupidity and greed.
First off, this is priced way out of whack. Should be half of the $5,000 price. Insurance companies would be lining up to pay for it rather than $1,400 a month sublocade.
Second, Braeburn paid $600 per treatment for the implant, but was unwilling to float doctors the $5,000 price pending insurance approval. So, they required the doctor (literally the "the middleman") to assume ALL the risk of nonpayment by the insurance company.
How about have the doctor/patient deposit the $600 cost of the rods, and then wait and see about insurance. If insurance doesn't pay, you haven't lost money, and you don't provide a second treatment.
That seems to be the strategy Indivior is utilizing. Much smarter.
First off, this is priced way out of whack. Should be half of the $5,000 price. Insurance companies would be lining up to pay for it rather than $1,400 a month sublocade.
Second, Braeburn paid $600 per treatment for the implant, but was unwilling to float doctors the $5,000 price pending insurance approval. So, they required the doctor (literally the "the middleman") to assume ALL the risk of nonpayment by the insurance company.
How about have the doctor/patient deposit the $600 cost of the rods, and then wait and see about insurance. If insurance doesn't pay, you haven't lost money, and you don't provide a second treatment.
That seems to be the strategy Indivior is utilizing. Much smarter.
Recent TTNP News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/14/2025 08:05:15 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/09/2025 09:30:37 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:30:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 12:21:28 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/02/2025 12:47:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 08:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2025 04:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/14/2025 09:16:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/22/2025 09:06:53 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 07/22/2025 09:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 08:15:19 PM
- Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 06/27/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 08:49:02 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2025 09:25:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 09:25:13 PM
- Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. • GlobeNewswire Inc. • 06/03/2025 12:45:44 PM
